Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Work In Process (2016 - 2022)

Historic Work In Process for Biomerica (BMRA) over the last 11 years, with Q1 2022 value amounting to $714000.0.

  • Biomerica's Work In Process fell 2780.59% to $714000.0 in Q1 2022 from the same period last year, while for Feb 2022 it was $714000.0, marking a year-over-year decrease of 2780.59%. This contributed to the annual value of $1.0 million for FY2021, which is 182.19% up from last year.
  • Per Biomerica's latest filing, its Work In Process stood at $714000.0 for Q1 2022, which was down 2780.59% from $708000.0 recorded in Q4 2021.
  • Biomerica's Work In Process' 5-year high stood at $1.5 million during Q4 2020, with a 5-year trough of $708000.0 in Q4 2021.
  • Its 5-year average for Work In Process is $904625.0, with a median of $872000.0 in 2018.
  • Per our database at Business Quant, Biomerica's Work In Process skyrocketed by 8155.69% in 2020 and then tumbled by 5329.82% in 2021.
  • Over the past 5 years, Biomerica's Work In Process (Quarter) stood at $791000.0 in 2018, then increased by 5.56% to $835000.0 in 2019, then soared by 81.56% to $1.5 million in 2020, then crashed by 53.3% to $708000.0 in 2021, then rose by 0.85% to $714000.0 in 2022.
  • Its Work In Process stands at $714000.0 for Q1 2022, versus $708000.0 for Q4 2021 and $926000.0 for Q3 2021.